Acute infection and myocardial infarction
DM Musher, MS Abers… - New England Journal of …, 2019 - Mass Medical Soc
Risk of MI after Acute Infection Among patients who are hospitalized for pneumococcal
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …
The microbial etiology of community-acquired pneumonia in adults: from classical bacteriology to host transcriptional signatures
NJ Gadsby, DM Musher - Clinical microbiology reviews, 2022 - Am Soc Microbiol
All modern advances notwithstanding, pneumonia remains a common infection with
substantial morbidity and mortality. Understanding of the etiology of pneumonia continues to …
substantial morbidity and mortality. Understanding of the etiology of pneumonia continues to …
Etiology of community-acquired pneumonia in adults: a systematic review
S Shoar, DM Musher - Pneumonia, 2020 - Springer
Background The etiology of community-acquired pneumonia (CAP) has evolved since the
beginning of the antibiotic era. Recent guidelines encourage immediate empiric antibiotic …
beginning of the antibiotic era. Recent guidelines encourage immediate empiric antibiotic …
Burden of community-acquired pneumonia and unmet clinical needs
J Ferreira-Coimbra, C Sarda, J Rello - Advances in therapy, 2020 - Springer
Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …
diseases and an important health problem, having considerable implications for healthcare …
Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis
IS Kamat, V Ramachandran, H Eswaran… - Clinical Infectious …, 2020 - academic.oup.com
Because of the diverse etiologies of community-acquired pneumonia (CAP) and the
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …
The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance
P Peyrani, L Mandell, A Torres… - Expert review of …, 2019 - Taylor & Francis
Introduction: Community-acquired pneumonia (CAP) is a significant global health problem
and leading cause of death and hospitalization in both the US and abroad. Increasing …
and leading cause of death and hospitalization in both the US and abroad. Increasing …
Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry …
F Zhou, Y Wang, Y Liu, X Liu, L Gu… - European …, 2019 - Eur Respiratory Soc
Although broad knowledge of influenza viral pneumonia has been established, the
significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) …
significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) …
[HTML][HTML] Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review
Background The burden of community-acquired pneumonia (CAP) caused by Streptococcus
pneumoniae (pneumococcus) among adults in Europe is poorly defined. Methods …
pneumoniae (pneumococcus) among adults in Europe is poorly defined. Methods …
Incidence, etiology, and outcomes of community-acquired pneumonia: a population-based study
Background The microbial etiology of community-acquired pneumonia (CAP) is often
unclear in clinical practice, and previous studies have produced variable results. Population …
unclear in clinical practice, and previous studies have produced variable results. Population …
Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia
Introduction Procalcitonin expression is thought to be stimulated by bacteria and suppressed
by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians …
by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians …